Ketotifen fumarate oral strips were formulated and evaluated. Hydroxypropyl methylcellulose was found to be the best film-forming polymer. Polyethylene glycol 400 was the best plasticizer. Decreasing HPMC concentration and increasing the hydrophilic surfactant tween 80 concentration led to faster disintegration and drug release. Formula F17 containing 61.64% HPMC, 21.14% PEG400 and 6.28% tween 80 showed the fastest disintegration time of 20.4 seconds and highest drug release of 74.77% within 2.1 minutes. The oral strips were stable for up to 3.5 years and could improve ketotifen fumarate bioavailability by avoiding
This document provides an overview of fast dissolving oral thin films (FDOTF). It begins with an introduction describing FDOTFs as thin polymeric strips that dissolve quickly in the mouth without water. The document then covers special features of FDOTFs, compares them to fast dissolving tablets, and describes their mechanism of action, classifications, properties, advantages, disadvantages, formulations, manufacturing methods, evaluation, and concludes with references.
Fast dissolving oral films are thin oral strips that rapidly disintegrate in the mouth without water. They were developed in the 1970s as an alternative to tablets and capsules. The document discusses the key features of oral films including their thin elegant shape, excellent mucoadhesion, and ability to rapidly release drugs. It also covers general properties like thickness, formulation methods like solvent casting, and evaluation tests for properties like disintegration and mechanical strength. The advantages of oral films are convenient dosing without water and potential for taste masking and avoidance of first pass metabolism. However, they are easily fragile and require special packaging.
Development and Characterisation of Fast Dissolving Oral FilmsPardeep Jangra
For My review article on Fast Dissolving Oral Films, click on this link http://www.ijupbs.com/Uploads/2.%20RPA13140283015.pdf or copy paste this link in browser.
Pardeep Kumar Jangra
This document provides an overview of mouth dissolving films and related patents. It discusses the composition, manufacturing methods, properties and evaluation tests of these films. Key points:
- Mouth dissolving films offer advantages over traditional oral dosage forms as they dissolve rapidly in the mouth without water.
- Films are typically made of water-soluble polymers, plasticizers, sweetening agents and active pharmaceutical ingredients. Common manufacturing methods are solvent casting, hot melt extrusion and rolling.
- Properties like thickness, tensile strength, disintegration time and drug release are evaluated. Many US patents cover the formulation of mouth dissolving films with different polymers, drugs and manufacturing processes.
This document discusses emerging trends in alternative drug delivery systems, focusing on orally disintegrating films (ODFs). It provides information on:
1. What drugs are and routes of drug administration including oral, parenteral, suppository, inhalational, and topical.
2. Details on oral dosage forms including pills, liquids, and thin films. It describes the mechanism of action for ODFs including mucoadhesion and absorption.
3. Advantages of ODFs include rapid onset, bypassing first pass metabolism, and improved patient compliance compared to other dosage forms. Example products incorporating drugs into ODFs are mentioned.
The document provides an overview of mouth dissolving tablets (MDTs), including definitions, significance, requirements, formulation methodologies, patented technologies, and evaluation. MDTs are also called orally disintegrating tablets that dissolve rapidly in the mouth without water within a few seconds. They provide advantages over traditional tablets like ease of administration for those who have difficulty swallowing. Common formulation methods include freeze drying, molding, spray drying, mass extrusion, and compaction. Patented technologies like OraSolv use effervescent agents that release gas upon contact with water to aid rapid disintegration.
This document discusses oral dissolving films (ODFs), which are thin films that dissolve quickly in the mouth. ODFs offer benefits like rapid onset of action, avoidance of first-pass metabolism, improved patient compliance, and ease of administration without water. The document reviews the process of ODF production, current products on the market, potential drugs that could be delivered via ODF, and a study developing a pantoprazole ODF using hydroxypropyl methylcellulose polymers. The study found that the lower viscosity HPMC LV polymer was more effective for rapid film disintegration and drug dissolution compared to the higher viscosity HPMC E 15 polymer.
Formulation & evaluation of fast dissolving oral filmGaju Shete
The document summarizes the formulation and evaluation of fast dissolving oral films containing metoclopramide HCl. Key points:
- Metoclopramide HCl was selected as the model drug and different polymers like HPMC, xanthan gum, guar gum and maltodextrin were used to prepare oral films. PEG 400 and glycerol were used as plasticizers.
- Preformulation studies like melting point, solubility, UV spectroscopy and FTIR were conducted on the drug. Compatibility studies showed no interactions between drug and polymers.
- 12 film formulations were prepared by solvent casting method using different concentrations of polymers. Films were evaluated for appearance, tackiness, film
This document provides an overview of fast dissolving oral thin films (FDOTF). It begins with an introduction describing FDOTFs as thin polymeric strips that dissolve quickly in the mouth without water. The document then covers special features of FDOTFs, compares them to fast dissolving tablets, and describes their mechanism of action, classifications, properties, advantages, disadvantages, formulations, manufacturing methods, evaluation, and concludes with references.
Fast dissolving oral films are thin oral strips that rapidly disintegrate in the mouth without water. They were developed in the 1970s as an alternative to tablets and capsules. The document discusses the key features of oral films including their thin elegant shape, excellent mucoadhesion, and ability to rapidly release drugs. It also covers general properties like thickness, formulation methods like solvent casting, and evaluation tests for properties like disintegration and mechanical strength. The advantages of oral films are convenient dosing without water and potential for taste masking and avoidance of first pass metabolism. However, they are easily fragile and require special packaging.
Development and Characterisation of Fast Dissolving Oral FilmsPardeep Jangra
For My review article on Fast Dissolving Oral Films, click on this link http://www.ijupbs.com/Uploads/2.%20RPA13140283015.pdf or copy paste this link in browser.
Pardeep Kumar Jangra
This document provides an overview of mouth dissolving films and related patents. It discusses the composition, manufacturing methods, properties and evaluation tests of these films. Key points:
- Mouth dissolving films offer advantages over traditional oral dosage forms as they dissolve rapidly in the mouth without water.
- Films are typically made of water-soluble polymers, plasticizers, sweetening agents and active pharmaceutical ingredients. Common manufacturing methods are solvent casting, hot melt extrusion and rolling.
- Properties like thickness, tensile strength, disintegration time and drug release are evaluated. Many US patents cover the formulation of mouth dissolving films with different polymers, drugs and manufacturing processes.
This document discusses emerging trends in alternative drug delivery systems, focusing on orally disintegrating films (ODFs). It provides information on:
1. What drugs are and routes of drug administration including oral, parenteral, suppository, inhalational, and topical.
2. Details on oral dosage forms including pills, liquids, and thin films. It describes the mechanism of action for ODFs including mucoadhesion and absorption.
3. Advantages of ODFs include rapid onset, bypassing first pass metabolism, and improved patient compliance compared to other dosage forms. Example products incorporating drugs into ODFs are mentioned.
The document provides an overview of mouth dissolving tablets (MDTs), including definitions, significance, requirements, formulation methodologies, patented technologies, and evaluation. MDTs are also called orally disintegrating tablets that dissolve rapidly in the mouth without water within a few seconds. They provide advantages over traditional tablets like ease of administration for those who have difficulty swallowing. Common formulation methods include freeze drying, molding, spray drying, mass extrusion, and compaction. Patented technologies like OraSolv use effervescent agents that release gas upon contact with water to aid rapid disintegration.
This document discusses oral dissolving films (ODFs), which are thin films that dissolve quickly in the mouth. ODFs offer benefits like rapid onset of action, avoidance of first-pass metabolism, improved patient compliance, and ease of administration without water. The document reviews the process of ODF production, current products on the market, potential drugs that could be delivered via ODF, and a study developing a pantoprazole ODF using hydroxypropyl methylcellulose polymers. The study found that the lower viscosity HPMC LV polymer was more effective for rapid film disintegration and drug dissolution compared to the higher viscosity HPMC E 15 polymer.
Formulation & evaluation of fast dissolving oral filmGaju Shete
The document summarizes the formulation and evaluation of fast dissolving oral films containing metoclopramide HCl. Key points:
- Metoclopramide HCl was selected as the model drug and different polymers like HPMC, xanthan gum, guar gum and maltodextrin were used to prepare oral films. PEG 400 and glycerol were used as plasticizers.
- Preformulation studies like melting point, solubility, UV spectroscopy and FTIR were conducted on the drug. Compatibility studies showed no interactions between drug and polymers.
- 12 film formulations were prepared by solvent casting method using different concentrations of polymers. Films were evaluated for appearance, tackiness, film
Oral Dispersible Film is a Novel Drug Delivery System intended to bypass the hepatic first pass metabolism and also many other benefits over the conventional oral dosage forms. It provides the user to administer the drug without the use of water and without ant expertise in administration.
Formulation Development and Evaluation of Oral Fast Dissolving Films of Metac...ijtsrd
Metaclopromide HCl is an Anti emetic used to treat nausea, vomiting and to increase gastric motility. The present work aimed at preparing oral fast dissolving films of Metaclopromide HCl with the purpose of developing a dosage form for a very quick onset of action, which is very convenient for administration, without the problem of swallowing and using water. Oral fast dissolving films of Metaclopromide HCl were prepared using HPMC E5, E15 polymers as film forming agents and polyethylene glycol 400 as plasticizer by solvent casting method. FTIR showed that there is no interaction between drug and excipients. Dissolution of prepared fast dissolving oral films of Metaclopromide HCl was performed using USP type II apparatus in pH 6.8 phosphate buffer medium at 50 rpm with temperature being maintained at 37 0.5º C. The films prepared were evaluated for various parameters like thickness, drug content uniformity, weight variation, disintegration time, folding endurance and in vitro drug release and were showed satisfactory results. In conclusion, development of oral fast dissolving oral films using HPMC polymer gives rapid drug delivery and rapid onset of action. Zeenath Ruhy "Formulation Development and Evaluation of Oral Fast Dissolving Films of Metaclopromide HCL" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-1 , December 2019, URL: https://www.ijtsrd.com/papers/ijtsrd29702.pdf Paper URL: https://www.ijtsrd.com/pharmacy/novel-drug-delivery-sys/29702/formulation-development-and-evaluation-of-oral-fast-dissolving-films-of-metaclopromide-hcl/zeenath-ruhy
Orally disintegrating tablets (ODTs) are solid dosage forms that disintegrate rapidly in the mouth. The first FDA-approved ODT was a Zydis formulation of Claritin in 1996. ODTs are suitable for patients who have difficulty swallowing pills like pediatric and geriatric patients. They have advantages like convenience of administration without water and faster onset of action. ODTs contain active ingredients, disintegrants, binders, flavors and other excipients. Common disintegrants include starches, crospovidone and celluloses. Formulation methods include freeze drying, moulding, sublimation and direct compression. Many drug classes have been formulated into ODTs for improved patient
This document provides details on the development of a mouth dissolving tablet formulation of meloxicam. It begins with an introduction on the benefits of mouth dissolving tablets and ideal properties. The document then outlines the aim to develop a solid dispersion technique to enhance the solubility of meloxicam and prepare mouth dissolving tablets. The plan of work, materials, and methods are described for characterizing the drug and excipients, preparing the solid dispersions using a kneading method, and evaluating the tablets. The evaluation would include hardness, thickness, friability, disintegration time, wetting time, drug content, and in vitro dissolution testing. References are also provided.
This document provides an overview of mouth dissolving films as an innovative drug delivery system. It discusses the anatomy and physiology of the oral cavity, advantages and disadvantages of mouth dissolving films, and the role of saliva. It also covers formulation ingredients, preparation methods like solvent casting, and evaluation parameters for mouth dissolving films such as mechanical properties, disintegration time, and in vitro dissolution testing. The document aims to educate about this drug delivery system for pediatric and geriatric patients.
Formulation and evaluation of fast dissolving tablet- by aryan and rajeshSridhar Sri
This document provides an overview of a study to formulate and evaluate fast dissolving tablets of domperidone. It begins with an introduction that defines fast dissolving tablets and lists their requirements and advantages. It then outlines the objectives, plan of work, drug and excipient profiles, materials, and methodology for the study. The methodology section describes preformulation tests conducted on domperidone as well as evaluation tests that will be performed on the formulated tablets, including disintegration time, drug content, and in vitro drug release. The document provides background information needed to understand and carry out the research project on developing a fast dissolving tablet of domperidone.
This document provides an overview of orally disintegrating tablets (ODTs), including:
1. The definition and ideal properties of ODTs according to regulatory agencies.
2. The large market potential and growth of ODTs globally, especially for drugs treating central nervous system and gastrointestinal conditions.
3. Important patented technologies for developing ODTs, such as Zydis® technology which uses a lyophilization process to create a porous structure for rapid disintegration.
4. Common excipients and formulation methods used in ODTs, including lyophilization, molding, and mass extrusion.
This document provides a review of oral dispersible tablets. It begins with an introduction that defines oral dispersible tablets as solid dosages that disintegrate rapidly, usually within seconds, when placed on the tongue. It describes the advantages of these tablets for patients who have difficulty swallowing conventional tablets. The document then reviews various technologies used to manufacture oral dispersible tablets, including lyophilization, molding, cotton candy process, and spray drying. It also discusses commonly used excipients and superdisintegrants and their mechanisms of action in rapidly disintegrating tablets.
Challenges in development of orally disintegrating and dispersible tabletsGaurav Kr
The document discusses orally disintegrating tablets (ODTs), including definitions, advantages over conventional tablets, challenges in formulation, materials required, mechanisms of drug release, formulation techniques, marketed products, evaluation tests, and future developments. It provides details on the conventional methods used to produce ODTs such as tablet molding, direct compression, spray drying, and freeze drying. It also discusses patented technologies for producing ODTs.
This document defines and discusses fast dissolving tablets (FDTs). FDTs disintegrate rapidly in the mouth without water. Their history dates back to the 1970s when scientists developed Zydis, an early FDT formulation. FDTs provide advantages like accurate dosing, easy administration for patients who can't swallow, and a faster onset of action compared to normal tablets. They are made through freeze drying or spray drying which creates a highly porous structure for rapid dissolution. While FDTs offer benefits, their use is limited by formulation challenges like bitter tasting drugs and large doses. The future of FDTs depends on overcoming these difficulties.
The document discusses orodispersible films as a drug delivery system. It provides an introduction to orodispersible films, describes their advantages over other dosage forms like tablets, and discusses various aspects of formulation such as polymers, plasticizers, and drug loading. The document also summarizes evaluation methods for orodispersible films and provides examples of marketed products in this category. In conclusion, it states that orodispersible films are considered a promising drug delivery system, especially for pediatric and geriatric patients due to their ease of administration.
The document discusses oral disintegrating tablets (ODTs), which are oral solid dosage forms that dissolve or disintegrate rapidly in the mouth without water. ODTs offer advantages over traditional tablets like improved patient compliance and bioavailability. Key attributes of ODTs include rapid disintegration (within 30 seconds), good taste masking, and the use of superdisintegrants, sugars, and other excipients to facilitate quick dissolution. Common technologies for producing ODTs involve freeze-drying, direct compression, spray drying, and mass extrusion. Preformulation studies and tests of disintegration time and dissolution profile are important for developing an effective ODT formulation.
This document discusses fast dissolution disintegrating dosage forms (FDDFs). It begins with an introduction to FDDFs, noting they dissolve or disintegrate quickly without water. The needs and advantages of FDDFs are then outlined, including ease of administration for those who have trouble swallowing. Various formulation methods, ingredients, and patented technologies are described. Several example formulations are provided. Clinical studies on bioavailability and pregastric absorption are mentioned. Popular commercial FDDF products are listed before concluding FDDFs can improve compliance by dissolving rapidly in the mouth.
PREPARATION AND EVALUATION OF FAST DISSOLVING LEVOCITRAZINE TABLETS1Depika Battu
This document summarizes a student research project on developing fast dissolving tablets of Levocetirizine dihydrochloride. It lists the students and supervisor involved. It then provides background information on fast dissolving tablets, including definitions, advantages, techniques for preparation, and mechanisms of mouth dissolving. The objectives and methodology of the study are described. Formulations of fast dissolving tablets containing Levocetirizine were developed and evaluated for pre-compression and post-compression parameters such as drug content and in vitro drug release. The optimized formulation showed 99.81% drug release within 10 minutes and disintegrated within 14 seconds.
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...IOSR Journals
The concept of mouth dissolving tablets known as MDTs has emerged with an objective to improve patient’s compliance. Methods to improve patient’s compliance have always attracted scientists towards the development of fancy oral drug delivery systems. Among them, mouth dissolving drug delivery systems (MDDDS) have obtained an important position in the market by overcoming previously encountered administration problems and contributing to extension of patent life. These dosage forms rapidly disintegrate in contact with saliva even within <60 seconds, an attribute that makes them highly attractive for paediatric, geriatric, bedridden patients and for active patients who are busy and in travelling may not have access to water. This special dosage form has some prerequisite criteria for formulation and this also involves the use of special techniques for large scale industrial production. The aim of this article is to review the advantages and disadvantages of MDTs, common excipients used in the formulation especially highlighting the use of superdisintegrating agents and taste masking agents in formulation and finally the popular methods used to produce large scale tablets for commercial purpose.
Thin film drug delivery (Oral dissolve film )Chouthri D
to know about oral dissolving films, ,thin film dds ,oral dissolve films ,oral dispersal film ,api ,advantage for oral thin film ,ingredient using in thin film ,colouring agent used in thin film ,semisolid casting method ,thin film manufacturing mathods ,solvent casting method ,hot melt extrusion ,roiling method ,plasticizer ,water soluble polymers ,comparing between odt and odf ,solid dispersion extrusion ,application of oral dissolving film ,composition of fds,surfactant,saliva stimulating agent,flavouring agent,thi film manufacturing video
Formulation and Evaluation of Ondansetron Oral Dispersible Tablet using Diffe...IIJSRJournal
Objective: The aim of this study was to develop a simple method for manufacturing oral dispersible tablets of ondansetron hydrochloride using direct compression method and to study the effect of different types and concentration of natural disintegrant (Isabgol mucilage, fenugreek mucilage and dehydrated banana powder) on the disintegrating characteristics of the tablets.
Method: Disintegrants extracted from Isabgol, fenugreek and banana powder were used in formulation of tablet using placket burman design in minitab. Then 13 different formulations (F1- F13) were prepared varying the concentration of selected natural disintegrant (Isabgol mucilage extract 6-15%). Formulated tablets were investigated for weight variation, hardness, thickness, disintegration, drug content, friability.
Result: The result obtained from disintegration study of tablets prepared using natural disintegrant obtained from isabgol mucilage indicates that the Isabgol with concentration 11.47% shows the disintegration time of 27 seconds.
Conclusion: Orodispersible tablet of ondansetron hydrochloride was found to be effective with natural disintegrant obtained from isabgol mucilage
Oral Films Development & Manufacturing in India - Current ScenarioSridhar Rudravarapu
This presentation depicts the current status of oral film development and manufacturing in India. Oral film (orodispersible & oromucosal film) is a novel and alternate dosage delivery system with a huge scope for application in the pharma and nutraceuticals industry. This presentation orients the customers at the level of patients, health professionals and manufacturing companies about the oral films product development process, manufacturing aspects, and regulatory steps involved in the approval of these by the drug control authority in India. This presentation aims to briefly cover all the aspects of oral films (orodispersible/oromucosal) development and manufacturing feasibility in India to maximize its application for multiple health and patient compliance benefits -- Sridhar Rudravarapu
Fast Dissolving Oral Film Of Donepezil HCl By Swapnil Patil Swapnil Patil
The document discusses the formulation and evaluation of oral fast dissolving films of Donepezil Hydrochloride for the treatment of Alzheimer's disease. Various polymers like HPMC, Pullulan, and PVA are screened for their film forming properties. The optimized formulation will be developed using a factorial design to study the effect of polymer concentration and plasticizer on the drug release.
This document discusses regulatory considerations for over-the-counter (OTC) drugs in India and the United States. It provides definitions of OTC drugs and differences between prescription and OTC drugs in both countries. The key criteria for classifying drugs as OTC in the US and India are described. The document also examines regulations around marketing authorization, labeling, and advertising of OTC drugs. It evaluates the branded bisacodyl product Dulcolax and generic bisacodyl product Bisomer 5 based on tests specified in the Indian Pharmacopoeia. The evaluation found both products met requirements. The document concludes with recommendations for improving OTC drug regulations and classification in India.
Oral Dispersible Film is a Novel Drug Delivery System intended to bypass the hepatic first pass metabolism and also many other benefits over the conventional oral dosage forms. It provides the user to administer the drug without the use of water and without ant expertise in administration.
Formulation Development and Evaluation of Oral Fast Dissolving Films of Metac...ijtsrd
Metaclopromide HCl is an Anti emetic used to treat nausea, vomiting and to increase gastric motility. The present work aimed at preparing oral fast dissolving films of Metaclopromide HCl with the purpose of developing a dosage form for a very quick onset of action, which is very convenient for administration, without the problem of swallowing and using water. Oral fast dissolving films of Metaclopromide HCl were prepared using HPMC E5, E15 polymers as film forming agents and polyethylene glycol 400 as plasticizer by solvent casting method. FTIR showed that there is no interaction between drug and excipients. Dissolution of prepared fast dissolving oral films of Metaclopromide HCl was performed using USP type II apparatus in pH 6.8 phosphate buffer medium at 50 rpm with temperature being maintained at 37 0.5º C. The films prepared were evaluated for various parameters like thickness, drug content uniformity, weight variation, disintegration time, folding endurance and in vitro drug release and were showed satisfactory results. In conclusion, development of oral fast dissolving oral films using HPMC polymer gives rapid drug delivery and rapid onset of action. Zeenath Ruhy "Formulation Development and Evaluation of Oral Fast Dissolving Films of Metaclopromide HCL" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-1 , December 2019, URL: https://www.ijtsrd.com/papers/ijtsrd29702.pdf Paper URL: https://www.ijtsrd.com/pharmacy/novel-drug-delivery-sys/29702/formulation-development-and-evaluation-of-oral-fast-dissolving-films-of-metaclopromide-hcl/zeenath-ruhy
Orally disintegrating tablets (ODTs) are solid dosage forms that disintegrate rapidly in the mouth. The first FDA-approved ODT was a Zydis formulation of Claritin in 1996. ODTs are suitable for patients who have difficulty swallowing pills like pediatric and geriatric patients. They have advantages like convenience of administration without water and faster onset of action. ODTs contain active ingredients, disintegrants, binders, flavors and other excipients. Common disintegrants include starches, crospovidone and celluloses. Formulation methods include freeze drying, moulding, sublimation and direct compression. Many drug classes have been formulated into ODTs for improved patient
This document provides details on the development of a mouth dissolving tablet formulation of meloxicam. It begins with an introduction on the benefits of mouth dissolving tablets and ideal properties. The document then outlines the aim to develop a solid dispersion technique to enhance the solubility of meloxicam and prepare mouth dissolving tablets. The plan of work, materials, and methods are described for characterizing the drug and excipients, preparing the solid dispersions using a kneading method, and evaluating the tablets. The evaluation would include hardness, thickness, friability, disintegration time, wetting time, drug content, and in vitro dissolution testing. References are also provided.
This document provides an overview of mouth dissolving films as an innovative drug delivery system. It discusses the anatomy and physiology of the oral cavity, advantages and disadvantages of mouth dissolving films, and the role of saliva. It also covers formulation ingredients, preparation methods like solvent casting, and evaluation parameters for mouth dissolving films such as mechanical properties, disintegration time, and in vitro dissolution testing. The document aims to educate about this drug delivery system for pediatric and geriatric patients.
Formulation and evaluation of fast dissolving tablet- by aryan and rajeshSridhar Sri
This document provides an overview of a study to formulate and evaluate fast dissolving tablets of domperidone. It begins with an introduction that defines fast dissolving tablets and lists their requirements and advantages. It then outlines the objectives, plan of work, drug and excipient profiles, materials, and methodology for the study. The methodology section describes preformulation tests conducted on domperidone as well as evaluation tests that will be performed on the formulated tablets, including disintegration time, drug content, and in vitro drug release. The document provides background information needed to understand and carry out the research project on developing a fast dissolving tablet of domperidone.
This document provides an overview of orally disintegrating tablets (ODTs), including:
1. The definition and ideal properties of ODTs according to regulatory agencies.
2. The large market potential and growth of ODTs globally, especially for drugs treating central nervous system and gastrointestinal conditions.
3. Important patented technologies for developing ODTs, such as Zydis® technology which uses a lyophilization process to create a porous structure for rapid disintegration.
4. Common excipients and formulation methods used in ODTs, including lyophilization, molding, and mass extrusion.
This document provides a review of oral dispersible tablets. It begins with an introduction that defines oral dispersible tablets as solid dosages that disintegrate rapidly, usually within seconds, when placed on the tongue. It describes the advantages of these tablets for patients who have difficulty swallowing conventional tablets. The document then reviews various technologies used to manufacture oral dispersible tablets, including lyophilization, molding, cotton candy process, and spray drying. It also discusses commonly used excipients and superdisintegrants and their mechanisms of action in rapidly disintegrating tablets.
Challenges in development of orally disintegrating and dispersible tabletsGaurav Kr
The document discusses orally disintegrating tablets (ODTs), including definitions, advantages over conventional tablets, challenges in formulation, materials required, mechanisms of drug release, formulation techniques, marketed products, evaluation tests, and future developments. It provides details on the conventional methods used to produce ODTs such as tablet molding, direct compression, spray drying, and freeze drying. It also discusses patented technologies for producing ODTs.
This document defines and discusses fast dissolving tablets (FDTs). FDTs disintegrate rapidly in the mouth without water. Their history dates back to the 1970s when scientists developed Zydis, an early FDT formulation. FDTs provide advantages like accurate dosing, easy administration for patients who can't swallow, and a faster onset of action compared to normal tablets. They are made through freeze drying or spray drying which creates a highly porous structure for rapid dissolution. While FDTs offer benefits, their use is limited by formulation challenges like bitter tasting drugs and large doses. The future of FDTs depends on overcoming these difficulties.
The document discusses orodispersible films as a drug delivery system. It provides an introduction to orodispersible films, describes their advantages over other dosage forms like tablets, and discusses various aspects of formulation such as polymers, plasticizers, and drug loading. The document also summarizes evaluation methods for orodispersible films and provides examples of marketed products in this category. In conclusion, it states that orodispersible films are considered a promising drug delivery system, especially for pediatric and geriatric patients due to their ease of administration.
The document discusses oral disintegrating tablets (ODTs), which are oral solid dosage forms that dissolve or disintegrate rapidly in the mouth without water. ODTs offer advantages over traditional tablets like improved patient compliance and bioavailability. Key attributes of ODTs include rapid disintegration (within 30 seconds), good taste masking, and the use of superdisintegrants, sugars, and other excipients to facilitate quick dissolution. Common technologies for producing ODTs involve freeze-drying, direct compression, spray drying, and mass extrusion. Preformulation studies and tests of disintegration time and dissolution profile are important for developing an effective ODT formulation.
This document discusses fast dissolution disintegrating dosage forms (FDDFs). It begins with an introduction to FDDFs, noting they dissolve or disintegrate quickly without water. The needs and advantages of FDDFs are then outlined, including ease of administration for those who have trouble swallowing. Various formulation methods, ingredients, and patented technologies are described. Several example formulations are provided. Clinical studies on bioavailability and pregastric absorption are mentioned. Popular commercial FDDF products are listed before concluding FDDFs can improve compliance by dissolving rapidly in the mouth.
PREPARATION AND EVALUATION OF FAST DISSOLVING LEVOCITRAZINE TABLETS1Depika Battu
This document summarizes a student research project on developing fast dissolving tablets of Levocetirizine dihydrochloride. It lists the students and supervisor involved. It then provides background information on fast dissolving tablets, including definitions, advantages, techniques for preparation, and mechanisms of mouth dissolving. The objectives and methodology of the study are described. Formulations of fast dissolving tablets containing Levocetirizine were developed and evaluated for pre-compression and post-compression parameters such as drug content and in vitro drug release. The optimized formulation showed 99.81% drug release within 10 minutes and disintegrated within 14 seconds.
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...IOSR Journals
The concept of mouth dissolving tablets known as MDTs has emerged with an objective to improve patient’s compliance. Methods to improve patient’s compliance have always attracted scientists towards the development of fancy oral drug delivery systems. Among them, mouth dissolving drug delivery systems (MDDDS) have obtained an important position in the market by overcoming previously encountered administration problems and contributing to extension of patent life. These dosage forms rapidly disintegrate in contact with saliva even within <60 seconds, an attribute that makes them highly attractive for paediatric, geriatric, bedridden patients and for active patients who are busy and in travelling may not have access to water. This special dosage form has some prerequisite criteria for formulation and this also involves the use of special techniques for large scale industrial production. The aim of this article is to review the advantages and disadvantages of MDTs, common excipients used in the formulation especially highlighting the use of superdisintegrating agents and taste masking agents in formulation and finally the popular methods used to produce large scale tablets for commercial purpose.
Thin film drug delivery (Oral dissolve film )Chouthri D
to know about oral dissolving films, ,thin film dds ,oral dissolve films ,oral dispersal film ,api ,advantage for oral thin film ,ingredient using in thin film ,colouring agent used in thin film ,semisolid casting method ,thin film manufacturing mathods ,solvent casting method ,hot melt extrusion ,roiling method ,plasticizer ,water soluble polymers ,comparing between odt and odf ,solid dispersion extrusion ,application of oral dissolving film ,composition of fds,surfactant,saliva stimulating agent,flavouring agent,thi film manufacturing video
Formulation and Evaluation of Ondansetron Oral Dispersible Tablet using Diffe...IIJSRJournal
Objective: The aim of this study was to develop a simple method for manufacturing oral dispersible tablets of ondansetron hydrochloride using direct compression method and to study the effect of different types and concentration of natural disintegrant (Isabgol mucilage, fenugreek mucilage and dehydrated banana powder) on the disintegrating characteristics of the tablets.
Method: Disintegrants extracted from Isabgol, fenugreek and banana powder were used in formulation of tablet using placket burman design in minitab. Then 13 different formulations (F1- F13) were prepared varying the concentration of selected natural disintegrant (Isabgol mucilage extract 6-15%). Formulated tablets were investigated for weight variation, hardness, thickness, disintegration, drug content, friability.
Result: The result obtained from disintegration study of tablets prepared using natural disintegrant obtained from isabgol mucilage indicates that the Isabgol with concentration 11.47% shows the disintegration time of 27 seconds.
Conclusion: Orodispersible tablet of ondansetron hydrochloride was found to be effective with natural disintegrant obtained from isabgol mucilage
Oral Films Development & Manufacturing in India - Current ScenarioSridhar Rudravarapu
This presentation depicts the current status of oral film development and manufacturing in India. Oral film (orodispersible & oromucosal film) is a novel and alternate dosage delivery system with a huge scope for application in the pharma and nutraceuticals industry. This presentation orients the customers at the level of patients, health professionals and manufacturing companies about the oral films product development process, manufacturing aspects, and regulatory steps involved in the approval of these by the drug control authority in India. This presentation aims to briefly cover all the aspects of oral films (orodispersible/oromucosal) development and manufacturing feasibility in India to maximize its application for multiple health and patient compliance benefits -- Sridhar Rudravarapu
Fast Dissolving Oral Film Of Donepezil HCl By Swapnil Patil Swapnil Patil
The document discusses the formulation and evaluation of oral fast dissolving films of Donepezil Hydrochloride for the treatment of Alzheimer's disease. Various polymers like HPMC, Pullulan, and PVA are screened for their film forming properties. The optimized formulation will be developed using a factorial design to study the effect of polymer concentration and plasticizer on the drug release.
This document discusses regulatory considerations for over-the-counter (OTC) drugs in India and the United States. It provides definitions of OTC drugs and differences between prescription and OTC drugs in both countries. The key criteria for classifying drugs as OTC in the US and India are described. The document also examines regulations around marketing authorization, labeling, and advertising of OTC drugs. It evaluates the branded bisacodyl product Dulcolax and generic bisacodyl product Bisomer 5 based on tests specified in the Indian Pharmacopoeia. The evaluation found both products met requirements. The document concludes with recommendations for improving OTC drug regulations and classification in India.
This document summarizes the formulation and evaluation of fast dissolving tablet dosages of felodipine. It discusses the drug profile, aim/objectives of developing fast dissolving tablets, materials/equipment used, preparation of formulations using different superdisintegrants (crospovidone, crosscarmellose sodium, sodium starch glycolate), and evaluation of tablet properties (thickness, hardness, friability) and performance (disintegration time, dissolution). 9 formulations were developed and evaluated, with F3 showing the fastest disintegration time of 116 seconds and highest drug release of 90.58% within 30 minutes. The study demonstrated the potential of using superdisintegrants to develop fast dissolving felodipine tablets for improved patient compliance and
The document discusses various types of special tablet formulations including buccal, sublingual, chewable tablets and lozenges. It covers the definitions, ingredients, manufacturing techniques and formulation factors for each type. Some key points discussed include the use of microencapsulation, adsorption, ion exchange and coatings to mask tastes. Recent developments mentioned are chewing gum formulations and melt-in-mouth tablets using sublimation to create pores for rapid disintegration.
This document provides an overview of buccal and sublingual drug delivery systems. It discusses the anatomy of the buccal mucosa and some of the advantages of buccal/sublingual routes, including avoidance of first-pass metabolism and protection from digestive enzymes. Various formulations are described, including tablets, patches, films, and semisolids. Evaluation methods like drug release studies, permeation studies, and bioadhesion tests are also summarized. The document provides a comprehensive introduction to buccal and sublingual drug delivery.
Thin films are layers of material ranging from fractions of a nanometer to several micrometers thick. Thin film technology involves precisely depositing individual atoms or molecules onto a substrate through various deposition techniques, including physical vapor deposition (PVD) and chemical vapor deposition (CVD). Key properties of thin films like thickness, roughness, and chemical composition must be carefully controlled. Thin films have many applications, such as in solar cells, batteries, medical device coatings, and more. Emerging areas of thin film application include biodegradable and flexible energy storage devices.
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...iosrphr_editor
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research paper publishing, where to publish research paper, journal publishing, how to publish research paper, Call for research paper, international journal, publishing a paper, call for paper 2012, journal of pharmacy, how to get a research paper published, publishing a paper, publishing of journal, research and review articles, Pharmacy journal, International Journal of Pharmacy, hard copy of journal, hard copy of certificates, online Submission, where to publish research paper, journal publishing, international journal, publishing a paper
Development and characterization of porous starch curcumin solid dispertion...NikitaGidde
1) The document discusses the preparation and evaluation of solid dispersions of curcumin and porous starch to enhance the solubility of curcumin.
2) Curcumin is poorly water soluble, so various ratios of curcumin-porous starch solid dispersions were prepared by ball milling.
3) The solid dispersions showed improved flow properties and a 1-2 fold increase in curcumin's solubility compared to curcumin alone. They also exhibited significantly faster drug dissolution.
Formulation and evaluation of mouth dissolving film containing antiemetic dru...siddhant thakur
The final presentation on the research topic of "FORMULATION AND EVALUATION OF MOUTH DISSOLVING FILM CONTAINING ANTIEMETIC DRUG FOR THE TREATMENT OF MOTION SICKNESS"
This presentation includes the Introduction about MDFs, Literature reviews, Statement of the research problem, Objectives of the study, Plan of research work, Drug selections, Preformulation studies, Design expert 11, Preparation of MDFs and Evaluations, Optimization of formulations and final conclusion
Devlopment and in vitro evaluation of gastroretentive floating tablets of fam...srirampharma
1) The document describes the development and in vitro evaluation of gastroretentive floating tablets containing famotidine.
2) Tablets were prepared using cellulose polymers (HPMC K4M, HPMC K15M, HPMC K100M) with gas generating agents (sodium bicarbonate, citric acid) by wet granulation.
3) The best performing formulation was found to be M15 containing HPMC K4M, sodium bicarbonate, citric acid and PVP K30, which showed desired drug release and buoyancy time. Stability studies showed no interaction between drug and polymers.
The document describes the preparation and evaluation of controlled release matrix tablets of metformin hydrochloride. Ten formulations of matrix tablets were prepared using different amounts of polymers HPMC K100 and Carbapol 934 by direct compression method. The tablets were evaluated for pre-compression and post-compression parameters. In vitro drug release studies showed sustained release of the drug from the matrix tablets over an extended period of time based on the type and concentration of polymer used. The kinetic analysis of drug release indicated that the release followed non-fickian or anomalous transport mechanism.
Formulation and evaluation of sustained release microspheres ofReshma Fathima .K
This document describes the formulation and evaluation of fenofibrate microspheres for sustained drug release. Fenofibrate microspheres were prepared using the emulsion-coacervation method with gelatin as the polymer. The microspheres were evaluated for particle size, drug entrapment efficiency, in vitro drug release, and stability. The results showed the microspheres had spherical morphology and successfully entrapped fenofibrate, providing sustained release over 12 hours. Thus, the fenofibrate microspheres developed in this study could be a promising approach for controlled delivery of this drug.
Formulation and evaluation of bi-layered floating tablets of metformin and te...SriramNagarajan17
The document describes the formulation and evaluation of bi-layer floating tablets containing metformin and telmisartan. Metformin was formulated as a sustained release layer using polymers like guar gum and xanthan gum, while telmisartan was formulated as an immediate release layer using superdisintegrants. Various pre-compression and post-compression evaluation tests were conducted on the powder blends and tablets. In vitro drug release studies showed that formulation F3 provided sustained release of metformin for up to 12 hours while F5 formulation released 100.6% of telmisartan within 30 minutes, indicating their suitability as a bi-layer floating tablet system.
This document summarizes the development of an in situ nasal gel drug delivery system for OHC-X. Key points:
1) An in situ nasal gel was developed using carbopol 940 and HPMC K4M polymers to increase residence time and reduce dosing frequency of OHC-X, which currently requires twice daily oral dosing.
2) Nine formulations were prepared varying the polymer concentrations. In vitro tests showed formulations F7-F9 formed gels immediately with extended gel strength.
3) In vitro drug release from these formulations was sustained over 6 hours with F7 showing best fit to Higuchi and Korsmeyer-Peppas models, indicating drug diffusion controlled release.
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...MilliporeSigma
Hot melt extrusion has successfully emerged as an innovative manufacturing technology in pharmaceutical industry for the creation of amorphous solid dispersions (ASDs).
In this webinar you will learn about the potential of hot melt extrusion to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA) as a matrix polymer. We will provide an overview about different types of solid dispersions and their evolution in the pharmaceutical field. A brief introduction in hot melt extrusion processing will be given as well as actual formulation trends. You will get insights in potential down-stream options to create your final dosage form and you will gain ideas on how to speed up your formulation development.
A detailed background of PVA will be provided including its physical properties as well as its regulatory status. PVA is more than a polymer. Due to its amphiphilic structure it has the potential to improve the supersaturation of low soluble APIs and to prevent precipitation after release. This highlights the versatility of PVA as an advanced polymer for HME applications and we will guide you through our latest research activities so that you can leverage our knowledge to improve your formulations.
This webinar includes:
- The current status and further potential of HME in pharmaceutical industry
- Advantages of PVA in the field of ASDs: Solubility improvement, impact on supersaturation potential, stability data generated on sample formulations & downstream options
- Deep dive into latest research activities: Permeation studies with Caco-2 cell membranes, pH shift studies to investigate supersaturation potential, ongoing research activities to get to know a more detailed understanding of matrix systems and their intermolecular interactions
In this webinar, you will learn:
- which potential hot melt extrusion has, to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA)
- why PVA is more than just a polymer
- how to create your final dosage form and speed up your formulation development
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...Merck Life Sciences
Hot melt extrusion has successfully emerged as an innovative manufacturing technology in pharmaceutical industry for the creation of amorphous solid dispersions (ASDs).
In this webinar you will learn about the potential of hot melt extrusion to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA) as a matrix polymer. We will provide an overview about different types of solid dispersions and their evolution in the pharmaceutical field. A brief introduction in hot melt extrusion processing will be given as well as actual formulation trends. You will get insights in potential down-stream options to create your final dosage form and you will gain ideas on how to speed up your formulation development.
A detailed background of PVA will be provided including its physical properties as well as its regulatory status. PVA is more than a polymer. Due to its amphiphilic structure it has the potential to improve the supersaturation of low soluble APIs and to prevent precipitation after release. This highlights the versatility of PVA as an advanced polymer for HME applications and we will guide you through our latest research activities so that you can leverage our knowledge to improve your formulations.
This webinar includes:
- The current status and further potential of HME in pharmaceutical industry
- Advantages of PVA in the field of ASDs: Solubility improvement, impact on supersaturation potential, stability data generated on sample formulations & downstream options
- Deep dive into latest research activities: Permeation studies with Caco-2 cell membranes, pH shift studies to investigate supersaturation potential, ongoing research activities to get to know a more detailed understanding of matrix systems and their intermolecular interactions
In this webinar, you will learn:
- which potential hot melt extrusion has, to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA)
- why PVA is more than just a polymer
- how to create your final dosage form and speed up your formulation development
Preformulation testing of solid dosage formsGaurav Kr
The document discusses preformulation testing, which is the first step in developing solid dosage forms and involves investigating a drug's physical and chemical properties alone and with excipients to generate useful information for formulating stable and bioavailable dosage forms. It outlines various characterization tests and properties that should be evaluated including solubility, particle size, purity, and surface area to guide formulation development and ensure batch-to-batch consistency.
This document discusses a research program between DuPont and a pharmaceutical company to develop stable suspension metered dose inhalers (MDIs) using hydrofluorocarbon (HFC) propellants. The research had two phases: 1) Characterizing the interactions between formulation components like drugs, surfactants, and propellants; and 2) Developing a high-pressure media milling process to integrate optimized formulations. The goal was to understand surfactant chemistry and develop a fundamental approach to achieve HFC performance equivalent to chlorofluorocarbon (CFC) MDIs. Promising formulations from phase 1 were processed in phase 2, demonstrating improved dispersion stability over unprocessed formulations. The research aimed to assist the transition to non
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)Mark_Sullivan
This document discusses polymorphism in solid-state materials and spectroscopy techniques for characterizing polymorphs. It provides examples of polymorphic drugs and outlines the importance of identifying and quantifying polymorphs. Techniques like FTIR, Raman, terahertz spectroscopy, solid-state NMR, and vibrational spectroscopy combined with multivariate analysis can be used to distinguish, identify, and quantify polymorphs in materials. Understanding polymorphism is crucial for developing drugs and ensuring consistent quality and performance throughout development and commercialization.
The document summarizes the design and development of itraconazole loaded nanosponges for topical drug delivery. It discusses the introduction to nanosponges, review of literature, aim and objectives of formulating itraconazole nanosponges, plan of work including materials and methods, formulation of nanosponges using the emulsion solvent diffusion method, evaluation studies of the nanosponges including production yield, entrapment efficiency, FT-IR spectroscopy, particle morphology by SEM, particle size analysis, and solubility study. The optimized nanosponge formulation F4 showed the highest production yield of 75.48%, entrapment efficiency of 73.10%, and solubility of 28 μg/
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay.
Solid dispersions are prepared to improve drug solubility, stability, taste masking and release profiles. They can exist as eutectic mixtures, solid solutions, glass solutions, amorphous precipitations, compound formations or combinations. Preparation methods include melting, solvent evaporation, and melting-solvent techniques. Characterization is done using thermal analysis, XRD, IR, NMR, dissolution studies and microscopy. Carriers should be stable, soluble, compatible with drugs and have low melting points. Solid dispersions provide benefits like increased dissolution and bioavailability but can be unstable over time.
Formulation and evaluation of Tretinoin emulgel – an advanced approach for enhanced topical drug delivery
This document discusses the formulation and evaluation of an emulgel containing the drug Tretinoin for topical delivery. Tretinoin emulgel was developed to improve the topical delivery and skin permeation of Tretinoin compared to conventional formulations. Various emulgel formulations with different concentrations of ingredients were prepared and evaluated based on parameters like physical appearance, pH, viscosity, drug content and diffusion studies. The results showed that formulations with optimal concentrations of surfactants and permeation enhancers demonstrated better properties for topical delivery of Tretinoin.
Formulation and evaluation of buccal disintegrating tablet of anticonvulsant ...AkshayAkotkar
This document discusses the formulation and evaluation of buccal disintegrating tablets of an anticonvulsant drug. It begins with an introduction to buccal drug delivery and the advantages of buccal disintegrating tablets over conventional dosage forms. The document then covers topics like permeability of drugs through oral mucosa, theories of adhesion, basic formulation components, and mechanisms of buccal disintegrating tablets. Nine formulations of gabapentin buccal tablets were developed and evaluated for characteristics like hardness, friability, drug content uniformity, disintegration time, and in-vitro drug release. Formulation F5 was found to have the highest drug release of 99.99% and was concluded to be the
4. Fast- dissolving drug delivery systems were first
developed in the late 1970s as an alternative to
conventional dosage forms for pediatric and
geriatric patients who experience difficulties
in swallowing traditional oral solid-dosage
forms
4
5. Lyophilized
systems
Fast-dissolve
technologies
Compressed
Oral thin
tablet-based
films (OTFs)
systems
5
6. Oral Strip
A thin film that is
prepared using
hydrophilic
polymers that
rapidly
dissolves on the
tongue or buccal
cavity
6
8. Solvent
casting
Electrostatic
spinning Hot melt
method extrusion
Manufacturing
Methods
Semisolid
Rolling
casting
Solid
dispersion
extrusion
8
9. Drug Used in the Study
Ketotifen Fumarate
C19H19NOS.C4H4O4
Mwt.= 425.50
pKa= 8.75
Log P = 4.99
Oral bioavailability
4-(1-Methylpiperidin-4-ylidene) - of 50% due to
4Hbenzo [4, 5] cyclohepta [1, 2-b] hepatic first pass
thiophen-10(9H)-one monofumarate metabolism
9
10. Aim of the Study
This study aims to formulate ketotifen fumarate
as oral dissolving films, to improve the
bioavailability by avoiding hepatic first-pass
metabolism
10
12. Determination of melting point
Determination of λ max
Construction of calibration curves
Fourier transform infrared spectroscopy (FTIR)
Determination of pH- solubility profile
12
13. Preparation of Ketotifen Fumarate Oral Films
Heating
Add
stirring
KF ,plasticizer, surfactant,
Na saccharin, citric acid and
Dissolving mannitol
polymer in Cooling to
20 ml D.W room
temperature
Rest for 24 drying
Dispersion hours to
stirred for remove all
30 minutes the air
bubbles
casting
13
15. Formulation Variables Studied
Type of film forming polymer
Type of plasticizer
Concentration of plasticizer
Concentration of the selected polymer
Type of surfactant
Concentration of surfactant
15
16. Evaluation of Ketotifen Fumarate Oral Films
Drug content uniformity
Visual inspection
Weight variation
Thickness measurements
Folding endurance
Tensile testing of the films (tensile strength ,
elastic modulus , percent elongation , strain )
Disintegration test ( in -vitro disintegration study
, in -vivo disintegration study)
Surface pH measurement
16
17. In –vitro dissolution study
Comparison of selected formula F17 with traditional
tablet (Zaditen® )and (Asmafort ®) for drug release
profile in 0.1 N HCL as dissolution medium
In –vitro permeation study
Drug polymer compatibility study
FTIR spectroscopy
o Drug
o Blank polymer
o Physical mixture of polymer and the drug
17
18. Stability Studies
Stability Studies (Effect of Humidity)
F17 stored at humidity oven 40˚C /75 ± 5 % RH for
duration of three months
Tested for various physical mechanical tests
Stability study
(Accelerated Temperature Effect)
F17 stored in ovens at different temperatures of
40°C, 50 ° C, and 60 ° C for three months and analysis
for drug content
18
19. Statistical analysis
One way analysis of variance (ANOVA) test was
used, and (P <0.05) was considered to be statistically
significant
19
21. Characterization of Ketotifen Fumarate
Determination of Melting Point
The melting point of ketotifen fumarate after drying was
190⁰C
Determination of λ max
UV scan in 0.1N HCL (pH 1.2), phosphate buffers (pH 6.8) and
(pH 7.4) showed λ max. at 300 nm
300 nm
21
26. Moderate
tensile
strength
High percent High
drug release %Elongation
Oral
Film
Short
disintegration High strain
time
Low elastic
modulus
26
27. Effect of type of polymer
Formula code In vivo DT(sec) Folding Strain T80%
endurance
F1(HPMC 6cp) 30.0±1 110 0.047 5.2
F2(NaCMC) 90.0±3.1 2 Not available 4
F3(PVA) 110.0±5 >300 1.48 1.8
F4(Gelatin) Not available Not available Not available Not available
F5 (Xanthan) 60.0±3.3 Not available Not available 40
27
28. Effect of type of plasticizers and their concentrations
Formula code In vivo DT(sec) Folding endurance Strain
F1(Gly 17.14%) 30.0±1 110 0.047
F6(Gly 21.14%) 29.0±2.5 128 0.049
F7(Gly 13.14%) 32.0±4.1 35 0.021
F8(PEG 17.14%) 31.0±1 220 0.035
F9(PEG 21.14%) 30.2±2 ˃300 0.056
F10(PEG 13.14%) 33.0±2.2 150 0.017
F11(PG 17.14%) 31.0±2.8 80 0.021
F12(PG 21.14%) 33.0±3.1 92 0.043
F13(PG 13.14%) 36.0±4 20 0.019
28
29. Effect of type of plasticizers and their concentrations
Formula F6 F8 F9 F10 F12
code
T80% 4.8 7.0 4.1 9.3 3.0
D2min% 57.3 37.05 55.45 28.33 63.07
29
30. Effect of Concentration of Hydroxypropyl
methylcellulose
Formula In vivo DT Folding Tensile T80% D2min%
code ( sec) Endurance Strength
(MPa)
F9(68.64%) 30.2±2 >300 13.41 4.1 55.45
F14(64.64%) 28.6±1 >300 12.88 4.1 61.93
F15(70.97%) 33.0±1 >300 14.76 4.6 51.53
F16(61.64% ) 24.6±2.5 >300 11.83 3.7 65.93
30
31. Effect of Type and Concentration of Surfactants
Formula In vivo DT Folding Strain T80% D2min%
code ( sec) Endurance
F17 20.4±1 >300 0.033 2.1 74.77
(tween 6.28%)
F18 38.6±1 >300 0.038 5.3 48.24
(span 6.28%)
31
34. In- vitro
Permeation
Study
The results indicated
that ketotifen fumarate
permeated through the
sheep sublingual mucosa
and hence could possibly
permeate through the
human buccal membrane
also
34
37. FTIR spectra of the physical mixture of ketotifen
fumarate and hydroxypropyl methylcellulose
37
38. Stability Studies( Effect of Humidity)
Properties Before storage After storage
Drug content% 98.10 97.5
Thickness(mm) 0.136 0.02 0.132 0.01
Tensile strength 11 10.8
Elongation % 3.31 2.77
Elastic modulus 332.32 389.89
Strain 0.033 0.027
Folding endurance ˃300 ˃300
In vivo DT(sec) 20.4 1 20.1 1
In vitro DT (sec) 22.74 1 21.5 2
Surface pH 5.9 6
38
39. Stability Studies( Effect of Temperature)
Temperature(°C) K (week-1)
40 1.5×10-3
50 3.08×10-3
60 4.6×10-3
The estimated shelf life of the selected formula was found to be 167.7
weeks or about 3.5 years
39
40. Conclusions
The best film forming polymer was hydroxypropyl
methylcellulose
Polyethylene Glycol 400 was the best plasticizer
Decreasing the concentration of HPMC resulted in faster
disintegration and drug release rates of ketotifen fumarate
oral films
The disintegration and the drug release rates were faster
for films prepared with hydrophilic surfactant (tween 80)
than that for films prepared with span 80
As the concentration of tween 80 is increased, both the
disintegration and the drug release rates increased
40
41. Amongst the nineteen formulas, the formula F17 which
contain (61.64% w/w) of HPMC, (21.14% w/w) of
PEG400, and (6.28%w/w) of tween 80 showed fastest
disintegration time 20.4seconds, T80% 2.1 minutes, the
D2 min % 74.77% and satisfactory mechanical properties
41
But the most commonly used industrial methods are the solvent casting and hot melt extrusion
The method can be summarized as follow
Nineteen formulas were prepared with their composition in this table
The spectrum was recorded for the drug ,blank polymer and physical mixture of the polymer and the drug
Oral film should possess …
Formula 17 showed fastest dissolution rate when compared with the traditional tablets
FTIR spectra of the physical mixture of the drug and HPMC shows the principal peaks related to pure drug which indicates that there is no incompatibility between the drug and the polymer used in the study
The results of stability study showed no significant difference in physico-mechanical characteristics after storage